Published in Neurosci Biobehav Rev on January 01, 1985
The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol (1985) 0.97
Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms. Neurosci Biobehav Rev (2012) 0.91
Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels. J Neurosci (2014) 0.85
A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. Br J Pharmacol (1995) 0.81
Comparison of infant and adult rats in exploratory activity, diurnal patterns, and responses to novel and anxiety-provoking environments. Behav Neurosci (2007) 0.81
Reciprocal activation/inactivation of ERK in the amygdala and frontal cortex is correlated with the degree of novelty of an open-field environment. Psychopharmacology (Berl) (2015) 0.77
Appropriate end points for the characterization of behavioral changes in developmental toxicology. Environ Health Perspect (1996) 0.77
Behavioral differences between late preweanling and adult female Sprague-Dawley rat exploration of animate and inanimate stimuli and food. Behav Brain Res (2010) 0.76
Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts. Br J Pharmacol (1989) 0.75
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav (1986) 2.73
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Can social interaction be used to measure anxiety? Br J Pharmacol (1978) 2.50
Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia (1975) 2.46
The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods (1980) 2.26
Sex differences in animal tests of anxiety. Physiol Behav (1991) 1.74
The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav (1996) 1.39
Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety. Pharmacol Biochem Behav (1999) 1.26
5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res (1996) 1.25
Do lorazeam-induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation? Br J Clin Pharmacol (1982) 1.20
Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) (2001) 1.13
The reliability of the hole-board apparatus. Psychopharmacologia (1975) 1.11
Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav (1987) 1.11
Effects of ethanol and chlordiazepoxide on social interaction in rats [proceedings]. Br J Pharmacol (1976) 1.10
Studies on the role of ACTH and of 5-HT in anxiety, using an animal model. J Pharm Pharmacol (1978) 1.10
Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem (2000) 1.08
Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull (1992) 1.07
Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol (1993) 1.07
Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology (Berl) (1979) 1.03
Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) (1997) 1.03
Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol (1999) 1.00
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav (2001) 1.00
The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) (2001) 0.99
Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol (2004) 0.98
Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berl) (1986) 0.98
Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol (1989) 0.97
Interaction between effects of caffeine and lorazepam in performance tests and self-ratings. J Clin Psychopharmacol (1982) 0.97
The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol (1985) 0.97
Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.95
Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav (1989) 0.95
Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology (Berl) (1984) 0.95
Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berl) (1999) 0.94
Corticosterone -- an anxiogenic or an anxiolytic agent? J Pharm Pharmacol (1979) 0.94
Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci (1998) 0.94
The anxiogenic action of benzodiazepine antagonists. Neuropharmacology (1982) 0.94
Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav Brain Res (1986) 0.93
Sedative effects of PK 9084 and PK 8165, alone and in combination with chlordiazepoxide. Br J Pharmacol (1983) 0.93
Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav (1998) 0.93
Mice lacking the cell adhesion molecule Thy-1 fail to use socially transmitted cues to direct their choice of food. Curr Biol (2000) 0.92
Methodological considerations in neurobehavioral teratology. Pharmacol Biochem Behav (1996) 0.92
Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology (1984) 0.92
Effects of two anxiolytics on distraction, habituation and dishabitiuation. Pharmacol Biochem Behav (1977) 0.91
5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol (1994) 0.91
Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology (1997) 0.91
Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res (1984) 0.90
The effects of piracetam on acquisition and retention of habituation [proceedings]. Br J Pharmacol (1977) 0.90
Regional differences in rat benzodiazepine binding in response to novelty and cat odour. Neuropharmacology (1994) 0.90
Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse. Psychopharmacology (Berl) (1983) 0.90
Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol (1987) 0.90
On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology (Berl) (1984) 0.90
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) (1999) 0.89
A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol Biochem Behav (1979) 0.89
Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine. Pharmacol Biochem Behav (2001) 0.89
A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci (1997) 0.89
Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci (2001) 0.89
Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology (Berl) (1979) 0.88
Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology (2003) 0.88
Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev (1985) 0.88
Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology (Berl) (1981) 0.88
Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology (1985) 0.88
Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance. Psychopharmacology (Berl) (1982) 0.88
Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav (1992) 0.87
In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology (2001) 0.87
5-HT and anxiety: promises and pitfalls. Pharmacol Biochem Behav (1986) 0.86
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav (1989) 0.86
Benzodiazepines reduce gastric ulcers induced in rats by stress. Br J Pharmacol (1981) 0.86
The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci (2000) 0.85
Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.85
Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors. Neuropharmacology (2000) 0.85
Behavioural and neurochemical responses of male and female chicks to cat odour. Pharmacol Biochem Behav (1996) 0.85
Responders and nonresponders to cat odor do not differ in other tests of anxiety. Pharmacol Biochem Behav (1994) 0.84
Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci (1999) 0.84
Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum. Physiol Behav (1983) 0.84
The effects of tricyclic and 'atypical' antidepressants on spontaneous locomotor activity in rodents. Neurosci Biobehav Rev (1986) 0.83
Changes in tonic immobility and the GABA-benzodiazepine system in response to handling in the chick. Pharmacol Biochem Behav (1997) 0.83
5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord (1979) 0.83
Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (1981) 0.83
Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull (1988) 0.83
The sensitivity of the rat corticosterone response to environmental manipulations and to chronic chlordiazepoxide treatment. Physiol Behav (1980) 0.83
Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors. J Neurol Neurosurg Psychiatry (1996) 0.83
Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology (1994) 0.83
The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol Behav (1985) 0.83
Dose tolerance to lorazepam develop with once weekly dosing? Br J Clin Pharmacol (1983) 0.83
Does the sedation resulting from sleep deprivation and lorazepam cause similar cognitive deficits? Pharmacol Biochem Behav (1998) 0.83
Sex differences in benzodiazepine binding in the frontal cortex and amygdala of the rat 24 hours after restraint stress. Neurosci Lett (1996) 0.83
Raised [3H]-5-HT release and 45Ca2+ uptake in diazepam withdrawal: inhibition by baclofen. Pharmacol Biochem Behav (1992) 0.82
Selective neurotoxin lesions of the lateral septum: changes in social and aggressive behaviours. Pharmacol Biochem Behav (1982) 0.82
Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors? Neurosci Lett (1985) 0.82
The locus coeruleus noradrenergic system--evidence against a role in attention, habituation, anxiety and motor activity. Brain Res (1978) 0.82
The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology (1986) 0.82
Is benzodiazepine-induced amnesia due to deactivation of the left prefrontal cortex? Psychopharmacology (Berl) (2000) 0.81
Behavioral consequences of antidepressant treatment in rodents. Neurosci Biobehav Rev (1986) 0.81
Effects of chlorpromazine on exploration and habituation in the rat. Br J Pharmacol (1973) 0.81
Social isolation modifies nicotine's effects in animal tests of anxiety. Br J Pharmacol (2001) 0.81
Do different mechanisms underlie two anxiogenic effects of systemic nicotine? Behav Pharmacol (2003) 0.81
Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence. Psychopharmacology (Berl) (1993) 0.81
Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam. J Clin Psychopharmacol (1983) 0.81
The nature of lorazepam-induced amnesia. Psychopharmacology (Berl) (1984) 0.81
Behavioural pharmacology of benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.81